Altamira Therapeutics Ltd. Current Liabilities
Altamira Therapeutics Ltd. (CYTOF) had Current Liabilities of $2.31 million as of 2025-06-30, per its 6-K filed 2025-08-29.
Financial Statements › Notes
ifrs-full:CurrentLiabilities · last filed 2025-08-29
- 2023-12-31: Current Liabilities 888.91K CHF.
- 2023-06-30: Current Liabilities 5.37M CHF.
- 2022-12-31: Current Liabilities 12.88M CHF.
- 2022-06-30: Current Liabilities 9.79M CHF.
CHF
| Period end | Current Liabilities |
|---|---|
| 2023-12-31 | 888.91K CHF 20-F/A · filed 2024-04-22 |
| 2023-06-30 | 5.37M CHF 6-K · filed 2023-09-12 |
| 2022-12-31 | 12.88M CHF 20-F/A · filed 2024-04-22 |
| 2022-06-30 | 9.79M CHF 6-K/A · filed 2023-08-21 |
| 2021-12-31 | 4.86M CHF 6-K/A · filed 2023-08-21 |
| 2021-06-30 | 3.07M CHF 6-K · filed 2021-09-08 |
| 2020-12-31 | 3.03M CHF 20-F · filed 2022-04-12 |
| 2020-06-30 | 2.42M CHF 6-K/A · filed 2020-09-17 |
| 2019-12-31 | 2.28M CHF 20-F · filed 2021-03-31 |
| 2019-06-30 | 1.78M CHF 6-K · filed 2019-08-15 |
| 2018-12-31 | 4.56M CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 10.43M CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 8.96M CHF 20-F · filed 2018-03-22 |
USD
| Period end | Current Liabilities |
|---|---|
| 2025-06-30 | $2.31M 6-K · filed 2025-08-29 |
| 2024-12-31 | $1.16M 6-K · filed 2025-08-29 |
| 2024-06-30 | $1.23M 6-K · filed 2024-09-24 |
| 2023-12-31 | $1.06M 20-F · filed 2025-04-30 |
| 2023-01-01 | $13.92M 20-F · filed 2025-04-30 |